VeriMomginsenoside rh4 hamilelikte güvenli mi?
No harmonised CLP classification, no SCCS or CIR cosmetic safety assessment specific to ginsenoside Rh4 was found and there are no published reproductive/teratology studies for Rh4; therefore hazard is default 0. However, some ginsenosides show estrogen-related or bioactive signaling effects in vitro and Rh4 shows biological activity in cultured cells and animal models (e.g. anti‑tumor, AMPK, gut/liver signaling), so a theoretical mechanistic concern (structural/class similarity to other ginsenosides) is noted (m=1). Topical cosmetic exposure is expected to give negligible systemic absorption for a large polar triterpenoid glycoside, so exposure is scored e=0 for pregnant adults. Sources: PubMed studies on Rh4 activity, ECHA substance info (no harmonised CLP), EWG ingredient entry.
Related ingredients
Frequently asked questions
- ginsenoside rh4 hamilelikte güvenli mi?
- No harmonised CLP classification, no SCCS or CIR cosmetic safety assessment specific to ginsenoside Rh4 was found and there are no published reproductive/teratology studies for Rh4; therefore hazard is default 0. However, some ginsenosides show estrogen-related or bioactive signaling effects in vitro and Rh4 shows biological activity in cultured cells and animal models (e.g. anti‑tumor, AMPK, gut/liver signaling), so a theoretical mechanistic concern (structural/class similarity to other ginsenosides) is noted (m=1). Topical cosmetic exposure is expected to give negligible systemic absorption for a large polar triterpenoid glycoside, so exposure is scored e=0 for pregnant adults. Sources: PubMed studies on Rh4 activity, ECHA substance info (no harmonised CLP), EWG ingredient entry.
- ginsenoside rh4 emzirirken güvenli mi?
- No data showing Rh4 transfers in breastmilk or causes reproductive/lactation toxicity; no regulatory flags (harmonised CLP / SCCS / CIR). Theoretical mechanistic concern retained (m=1) because ginsenosides as a class have bioactivity in vitro and some other ginsenosides have shown estrogen receptor interactions in studies. Expected topical exposure and transfer to milk is low → e=0 for topical use. Relevant data on whole‑ginseng in LactMed highlights general ginseng concerns but does not provide Rh4‑specific breastfeeding data.
- ginsenoside rh4 bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental toxicity data for Rh4 and no regulatory reproductive classification were identified, so hazard remains 0. Mechanistic score not increased because there is no infant‑specific mechanistic evidence. Exposure for baby skin is increased by +1 from adult (adult e=0 → baby e=1) because infant skin has higher permeability and surface‑area‑to‑weight; Rh4 is not demonstrated to be non‑absorbable. No data were found showing topical Rh4 causes adverse effects in infants 0–3 y.
- VeriMom ginsenoside rh4 nasıl puanlıyor?
- VeriMom ginsenoside rh4'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte ginsenoside rh4 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.